GLYCOMACROPEPTIDE AND ESSENTIAL AMINO ACIDS WITH VITAMINS AND MINERALS

Information current as at: 1 June 2026

Legend: Completed N In progress Not applicable N Yet to commence

Submission Details

Brand name:
  • PKU Build 10
Form and strength:
Please search for and view the medicine's Public Summary Document (PSD) for more information
Submission sponsor:
CORTEX HEALTH PTY LTD
Condition/indication:
(therapeutic use)
  • Phenylketonuria (PKU)
Listing requested:
Please see PSD for more information
Funding program:
Please see PSD for more information
Request authority level:
Please see PSD for more information
PBAC Submission type:
New PBS listing (Committee Secretariat)
Comment:
--
Other PBAC consideration:
--

Progress Details

Submission received for:
November 2024 PBAC meeting
Opportunity for consumer comment:
Open 31/07/2024 and close 25/09/2024 (see PBS Website)
PBAC meeting:
Held on 06/11/2024
PBAC outcome published:
Recommended (see PBAC Outcomes)
Notice of intent submitted:
15/01/2025
Lodgement of required documentation:
31/01/2025
Acceptance of complete documentation:
Accepted
Agreement to listing arrangements:
Commenced on 10/02/2025
Status:
Finalised
Government processes:
Commenced on 20/02/2025
Medicine listed on the PBS:
01/05/2025 (see PBS schedule)

PBAC Outcome

PBAC Recommendation:
Please see the Outcomes from the relevant meeting for more information

Case ID
a939
Page last updated
31 March 2026
v.9.19